{"id":40736,"date":"2025-12-09T13:26:37","date_gmt":"2025-12-09T13:26:37","guid":{"rendered":"https:\/\/indogenmed.org\/product\/tagrix-80-mg-tablets-2\/"},"modified":"2026-03-13T11:00:46","modified_gmt":"2026-03-13T11:00:46","slug":"tagrix-80-mg-tablets","status":"publish","type":"product","link":"https:\/\/indogenmed.org\/ja\/product\/tagrix-80-mg-tablets\/","title":{"rendered":"\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320"},"content":{"rendered":"<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\uff1a\u7528\u9014\u3001\u52b9\u679c\u3001\u7528\u91cf\u3001\u4fa1\u683c<\/h2>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u3054\u7d39\u4ecb<\/h2>\n<p>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306f\u3001\u7279\u5b9a\u306e\u4e0a\u76ae\u6210\u9577\u56e0\u5b50\u53d7\u5bb9\u4f53\uff08EGFR\uff09\u5909\u7570\u3092\u6709\u3059\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\uff08NSCLC\uff09\u60a3\u8005\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u308b\u6a19\u7684\u304c\u3093\u6cbb\u7642\u85ac\u3067\u3059\u3002\u30d3\u30fc\u30b3\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u304c\u88fd\u9020\u3057\u3001\u7b2c3\u4e16\u4ee3\u30c1\u30ed\u30b7\u30f3\u30ad\u30ca\u30fc\u30bc\u963b\u5bb3\u5264\uff08TKI\uff09\u3067\u3042\u308b<a href=\"https:\/\/indogenmed.org\/ja\/resource\/osimertinib-first-line-therapy-approvals-for-lung-cancer\/\" target=\"_blank\" rel=\"noopener\">\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6<\/a>\u3092\u542b\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u30fb\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306f\u3001\u80ba\u304c\u3093\u306b\u304a\u3051\u308b\u5236\u5fa1\u4e0d\u80fd\u306a\u7d30\u80de\u5897\u6b96\u3068\u816b\u760d\u5f62\u6210\u3092\u5f15\u304d\u8d77\u3053\u3059\u7570\u5e38\u306aEGFR\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u3067\u4f5c\u7528\u3057\u307e\u3059\u3002\u3053\u306e\u6a19\u7684\u6cbb\u7642\u306f\u3001\u304c\u3093\u7d30\u80de\u306e\u9032\u884c\u3092\u9045\u3089\u305b\u305f\u308a\u3001\u505c\u6b62\u3055\u305b\u305f\u308a\u3059\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306f\u3001\u5c40\u6240\u9032\u884c\u6027\u307e\u305f\u306f\u8ee2\u79fb\u6027NSCLC\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u3066\u304a\u308a\u3001\u816b\u760d\u306bT790M\u5909\u7570\u304c\u751f\u3058\u305f\u5834\u5408\u3082\u542b\u307e\u308c\u307e\u3059\u3002T790M\u5909\u7570\u306f\u3001\u304c\u3093\u3092\u5f93\u6765\u306eEGFR-TKI\u7642\u6cd5\u306b\u5bfe\u3057\u3066\u8010\u6027\u306b\u3059\u308b\u3053\u3068\u304c\u591a\u3044\u5909\u7570\u3067\u3059\u3002\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306f\u3001\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3068\u3057\u3066\u4e16\u754c\u7684\u306b\u5e83\u304f\u8a8d\u77e5\u3055\u308c\u3066\u304a\u308a\u3001\u591a\u304f\u306e\u56fd\u3067EGFR\u5909\u7570\u80ba\u304c\u3093\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306e\u7528\u9014<\/h2>\n<p>\u533b\u5e2b\u306f\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u3044\u304f\u3064\u304b\u306e\u80ba\u304c\u3093\u6cbb\u7642\u76ee\u7684\u3067\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u3092\u51e6\u65b9\u3059\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<ul>\n<li> EGFR\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u8ee2\u79fb\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u7b2c\u4e00\u9078\u629e\u6cbb\u7642<\/li>\n<li>\u4ee5\u524d\u306eEGFR\u963b\u5bb3\u5264\u306b\u5bfe\u3059\u308b\u8010\u6027\u3092\u793a\u3059T790M\u5909\u7570\u3092\u6709\u3059\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u6cbb\u7642<\/li>\n<li>\u816b\u760d\u5207\u9664\u624b\u8853\u5f8c\u306e\u88dc\u52a9\u7642\u6cd5\u306b\u3088\u308b\u764c\u518d\u767a\u30ea\u30b9\u30af\u306e\u4f4e\u6e1b<\/li>\n<li>\u4ed6\u306eEGFR\u6a19\u7684\u7642\u6cd5\u5f8c\u306b\u764c\u304c\u9032\u884c\u3057\u305f\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642<\/li>\n<\/ul>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306e\u4f5c\u7528\u6a5f\u5e8f<\/h2>\n<p>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\u306f\u3001\u304c\u3093\u7d30\u80de\u306b\u5b58\u5728\u3059\u308b\u5909\u7570\u578bEGFR\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u6a19\u7684\u3068\u3057\u3066\u963b\u5bb3\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u306e\u85ac\u5264\u306f\u4ee5\u4e0b\u306e\u52b9\u679c\u3092\u767a\u63ee\u3057\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u304c\u3093\u7d30\u80de\u306e\u7570\u5e38\u306a\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u3092\u963b\u6b62\u3059\u308b<\/li>\n<li>\u816b\u760d\u306e\u5897\u6b96\u3092\u9045\u3089\u305b\u308b<\/li>\n<li>\u80ba\u304c\u3093\u7d30\u80de\u306e\u5897\u6b96\u3092\u963b\u6b62\u3059\u308b<\/li>\n<\/ul>\n<p>\u3053\u306e\u6a19\u7684\u6307\u5411\u578b\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308a\u3001\u85ac\u5264\u306f\u5065\u5eb7\u306a\u7d30\u80de\u3078\u306e\u30c0\u30e1\u30fc\u30b8\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u3064\u3064\u3001\u304c\u3093\u7d30\u80de\u3060\u3051\u3092\u7279\u7570\u7684\u306b\u653b\u6483\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308b\u3002<\/p>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306e\u670d\u7528\u65b9\u6cd5<\/h2>\n<p>\u60a3\u8005\u306f\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u3092\u533b\u5e2b\u306e\u6307\u793a\u3069\u304a\u308a\u306b\u670d\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u4f7f\u7528\u4e0a\u306e\u6ce8\u610f\uff1a<\/p>\n<ul>\n<li>\u9320\u5264\u3092\u6c34\u3067\u4e38\u3054\u3068\u98f2\u307f\u8fbc\u3093\u3067\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u9320\u5264\u3092\u7815\u3044\u305f\u308a\u3001\u565b\u3093\u3060\u308a\u3001\u5272\u3063\u305f\u308a\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u98df\u4e8b\u306e\u6709\u7121\u306b\u304b\u304b\u308f\u3089\u305a\u670d\u7528\u3067\u304d\u307e\u3059<\/li>\n<li>\u6bce\u65e5\u540c\u3058\u6642\u9593\u306b\u670d\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u5b89\u5b9a\u3057\u305f\u52b9\u679c\u304c\u5f97\u3089\u308c\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>\u6b63\u3057\u3044\u670d\u7528\u91cf\u306b\u3064\u3044\u3066\u306f\u3001\u5fc5\u305a\u533b\u7642\u5f93\u4e8b\u8005\u306e\u6307\u793a\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n<h2>\u85ac\u7269\u76f8\u4e92\u4f5c\u7528<\/h2>\n<p>\u4e00\u90e8\u306e\u85ac\u5264\u306f\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u30fb\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u4f5c\u7528\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u305f\u308a\u3001\u526f\u4f5c\u7528\u306e\u30ea\u30b9\u30af\u3092\u9ad8\u3081\u305f\u308a\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u76f8\u4e92\u4f5c\u7528\u3092\u8d77\u3053\u3059\u53ef\u80fd\u6027\u306e\u3042\u308b\u4e00\u822c\u7684\u306a\u85ac\u5264\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n<ul>\n<li>\u6297\u771f\u83cc\u85ac<\/li>\n<li>\u6297\u3051\u3044\u308c\u3093\u85ac<\/li>\n<li>\u30ea\u30d5\u30a1\u30f3\u30d4\u30b7\u30f3\uff08\u6297\u751f\u7269\u8cea\uff09<\/li>\n<li>\u30ef\u30eb\u30d5\u30a1\u30ea\u30f3\u306a\u3069\u306e\u8840\u6db2\u51dd\u56fa\u6291\u5236\u5264<\/li>\n<\/ul>\n<p>\u670d\u7528\u3057\u3066\u3044\u308b\u3059\u3079\u3066\u306e\u85ac\u3001\u30d3\u30bf\u30df\u30f3\u5264\u3001\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u306b\u3064\u3044\u3066\u3001\u5fc5\u305a\u533b\u5e2b\u306b\u4f1d\u3048\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u526f\u4f5c\u7528<\/h2>\n<p>\u307b\u3068\u3093\u3069\u306e\u304c\u3093\u6cbb\u7642\u85ac\u3068\u540c\u69d8\u306b\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u3082\u7279\u5b9a\u306e\u526f\u4f5c\u7528\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002 <a href=\"https:\/\/indogenmed.org\/ja\/resource\/osimertinib-side-effects-common-long-term-risks\/\" target=\"_blank\" rel=\"noopener\">\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u4e00\u822c\u7684\u306a\u526f\u4f5c\u7528<\/a>\u306b\u306f\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u3082\u306e\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u4e0b\u75e2<\/li>\n<li>\u76ae\u819a\u306e\u767a\u75b9<\/li>\n<li>\u5026\u6020\u611f<\/li>\n<li>\u98df\u6b32\u6e1b\u9000<\/li>\n<li>\u53e3\u5185\u708e<\/li>\n<li>\u4e7e\u71e5\u808c<\/li>\n<li>\u722a\u306e\u5909\u5316<\/li>\n<li>\u8840\u7403\u6570\u6e1b\u5c11<\/li>\n<li>\u611f\u67d3\u30ea\u30b9\u30af\u306e\u5897\u52a0<\/li>\n<\/ul>\n<p>\u526f\u4f5c\u7528\u304c\u91cd\u5ea6\u306b\u306a\u3063\u305f\u308a\u3001\u6301\u7d9a\u3057\u305f\u308a\u3059\u308b\u5834\u5408\u306f\u3001\u533b\u5e2b\u306b\u9023\u7d61\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u670d\u7528\u524d\u306e\u6ce8\u610f\u4e8b\u9805<\/h2>\n<p>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u3092\u4f7f\u7528\u3059\u308b\u524d\u306b\u3001\u60a3\u8005\u306f\u4ee5\u4e0b\u306e\u6ce8\u610f\u4e8b\u9805\u3092\u8003\u616e\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<ul>\n<li>\u598a\u5a20\u4e2d\u306f\u80ce\u5150\u306b\u60aa\u5f71\u97ff\u3092\u53ca\u307c\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u305f\u3081\u3001\u4f7f\u7528\u3092\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u6388\u4e73\u4e2d\u306f\u4f7f\u7528\u524d\u306b\u533b\u5e2b\u306b\u76f8\u8ac7\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u809d\u81d3\u3084\u814e\u81d3\u306b\u554f\u984c\u306e\u3042\u308b\u60a3\u8005\u306f\u3001\u6295\u4e0e\u91cf\u306e\u8abf\u6574\u304c\u5fc5\u8981\u306b\u306a\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li>\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u306f\u5fc3\u62cd\u30ea\u30ba\u30e0\u306e\u5909\u5316\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u305f\u3081\u3001\u5fc3\u81d3\u75be\u60a3\u306e\u3042\u308b\u60a3\u8005\u306f\u533b\u5e2b\u306b\u305d\u306e\u65e8\u3092\u4f1d\u3048\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>\u6cbb\u7642\u4e2d\u306f\u3001\u5b9a\u671f\u7684\u306a\u7d4c\u904e\u89b3\u5bdf\u3068\u533b\u5e2b\u306b\u3088\u308b\u76e3\u7763\u304c\u91cd\u8981\u3067\u3059\u3002<\/p>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u5bfe\u30bf\u30b0\u30ea\u30c3\u30bd<\/h2>\n<p>\u60a3\u8005\u3055\u3093\u304b\u3089\u3088\u304f\u805e\u304b\u308c\u308b\u8cea\u554f\u306e\u4e00\u3064\u306b\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u3068\u30bf\u30b0\u30ea\u30c3\u30bd\u306e\u9055\u3044\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<ul>\n<li><a href=\"https:\/\/indogenmed.org\/ja\/product\/tagrisso-80mg-tablets\/\" target=\"_blank\" rel=\"noopener\">\u30bf\u30b0\u30ea\u30c3\u30bd\u306f<\/a>\u3001\u30a2\u30b9\u30c8\u30e9\u30bc\u30cd\u30ab\u793e\u304c\u958b\u767a\u3057\u305f\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u30aa\u30ea\u30b8\u30ca\u30eb\u30d6\u30e9\u30f3\u30c9\u540d\u3067\u3059\u3002<\/li>\n<li>\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u306f\u3001\u30d3\u30fc\u30b3\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u304c\u88fd\u9020\u3059\u308b\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3067\u3059\u3002<\/li>\n<\/ul>\n<p>\u4e21\u85ac\u5264\u306f\u540c\u3058\u6709\u52b9\u6210\u5206\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\u3092\u542b\u307f\u3001EGFR\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u80ba\u304c\u3093\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066\u540c\u69d8\u306e\u4f5c\u7528\u6a5f\u5e8f\u3092\u793a\u3059\u3002\u3057\u304b\u3057\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u306f\u901a\u5e38\u3001\u4fa1\u683c\u304c\u5b89\u3044\u305f\u3081\u3001\u591a\u304f\u306e\u60a3\u8005\u306b\u3068\u3063\u3066\u3088\u308a\u624b\u9803\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3068\u306a\u3063\u3066\u3044\u308b\u3002<\/p>\n<h2>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u4fa1\u683c\u3068\u30b3\u30b9\u30c8<\/h2>\n<p>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u4fa1\u683c\u306f\u3001\u4f9b\u7d66\u696d\u8005\u3001\u85ac\u5c40\u3001\u56fd\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u307e\u3059\u3002\u4e00\u822c\u7684\u306b\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u306e\u4fa1\u683c\u306f<a href=\"https:\/\/indogenmed.org\/ja\/resource\/why-tagrisso-expensive-generic-alternatives-tagrisso\/\" target=\"_blank\" rel=\"noopener\">\u30bf\u30b0\u30ea\u30c3\u30bd<\/a>\u3088\u308a\u3082\u5927\u5e45\u306b\u4f4e\u3044\u305f\u3081\u3001\u9577\u671f\u7684\u306aEGFR\u6a19\u7684\u7642\u6cd5\u3092\u5fc5\u8981\u3068\u3059\u308b\u60a3\u8005\u306b\u3068\u3063\u3066\u8cbb\u7528\u5bfe\u52b9\u679c\u306e\u9ad8\u3044\u9078\u629e\u80a2\u3068\u306a\u308a\u307e\u3059\u3002\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u6700\u65b0\u4fa1\u683c\u306b\u3064\u3044\u3066\u306f\u3001\u6b63\u898f\u306e\u533b\u85ac\u54c1\u8ca9\u58f2\u696d\u8005\u307e\u305f\u306f\u8a8d\u53ef\u3092\u53d7\u3051\u305f\u30aa\u30f3\u30e9\u30a4\u30f3\u85ac\u5c40\u306b\u304a\u554f\u3044\u5408\u308f\u305b\u304f\u3060\u3055\u3044\u3002<\/p>\n<h2>\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3 data-section-id=\"1ujn849\" data-start=\"69\" data-end=\"108\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306f\u4f55\u306e\u305f\u3081\u306b\u4f7f\u7528\u3055\u308c\u308b\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p data-start=\"109\" data-end=\"288\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306f\u3001\u7279\u5b9a\u306eEGFR\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\uff08NSCLC\uff09\u60a3\u8005\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u307e\u3059\u3002\u304c\u3093\u7d30\u80de\u306e\u5897\u6b96\u3092\u9045\u3089\u305b\u305f\u308a\u3001\u505c\u6b62\u3055\u305b\u305f\u308a\u3059\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002<\/p>\n<h3 data-section-id=\"1tvyx95\" data-start=\"290\" data-end=\"330\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u3068\u30bf\u30b0\u30ea\u30c3\u30bd\u306f\u540c\u3058\u3082\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p data-start=\"331\" data-end=\"518\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u3068\u30bf\u30b0\u30ea\u30c3\u30bd\u306f\u3069\u3061\u3089\u3082\u540c\u3058\u6709\u52b9\u6210\u5206\u3067\u3042\u308b\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u3092\u542b\u3093\u3067\u3044\u307e\u3059\u3002\u30bf\u30b0\u30ea\u30c3\u30bd\u306f\u5148\u767a\u54c1\u3067\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u306f\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3067\u3042\u308a\u3001\u901a\u5e38\u306f\u3088\u308a\u4f4e\u4fa1\u683c\u3067\u5165\u624b\u3067\u304d\u307e\u3059\u3002<\/p>\n<h3 data-section-id=\"1b8n306\" data-start=\"520\" data-end=\"567\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306f\u3069\u306e\u3088\u3046\u306b\u670d\u7528\u3059\u308c\u3070\u3088\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p data-start=\"568\" data-end=\"725\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306f\u3001\u533b\u5e2b\u306e\u6307\u793a\u3069\u304a\u308a\u306b\u670d\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u9320\u5264\u306f\u6c34\u3067\u4e38\u3054\u3068\u98f2\u307f\u8fbc\u307f\u3001\u98df\u4e8b\u306e\u6709\u7121\u306f\u554f\u3044\u307e\u305b\u3093\u3002\u6bce\u65e5\u540c\u3058\u6642\u9593\u306b\u670d\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n<h3 data-section-id=\"1y404d7\" data-start=\"727\" data-end=\"791\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\u306e\u4e00\u822c\u7684\u306a\u526f\u4f5c\u7528\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p data-start=\"792\" data-end=\"972\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\u306e\u4e00\u822c\u7684\u306a\u526f\u4f5c\u7528\u306b\u306f\u3001\u4e0b\u75e2\u3001\u767a\u75b9\u3001\u5026\u6020\u611f\u3001\u76ae\u819a\u306e\u4e7e\u71e5\u3001\u53e3\u5185\u708e\u3001\u98df\u6b32\u4e0d\u632f\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u3002\u526f\u4f5c\u7528\u304c\u91cd\u7be4\u306b\u306a\u3063\u305f\u5834\u5408\u306f\u3001\u533b\u5e2b\u306b\u3054\u76f8\u8ac7\u304f\u3060\u3055\u3044\u3002<\/p>\n<h3 data-section-id=\"1o8q9y4\" data-start=\"974\" data-end=\"1017\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u4fa1\u683c\u306f\u3044\u304f\u3089\u3067\u3059\u304b\uff1f<\/h3>\n<p data-start=\"1018\" data-end=\"1179\">\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u4fa1\u683c\u306f\u85ac\u5c40\u3084\u5730\u57df\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u307e\u3059\u304c\u3001\u4e00\u822c\u7684\u306b\u306f\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u30aa\u30ea\u30b8\u30ca\u30eb\u30d6\u30e9\u30f3\u30c9\uff08\u30bf\u30b0\u30ea\u30c3\u30bd\uff09\u3088\u308a\u3082\u624b\u9803\u306a\u4fa1\u683c\u3067\u3059\u3002<\/p>\n<h2 data-start=\"1018\" data-end=\"1179\">\u53c2\u8003\u6587\u732e<\/h2>\n<ol data-start=\"100\" data-end=\"637\">\n<li data-section-id=\"p65ktw\" data-start=\"100\" data-end=\"225\">\n<p data-start=\"103\" data-end=\"225\"><strong data-start=\"103\" data-end=\"147\">\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u3002<\/strong><br data-start=\"147\" data-end=\"150\" \/>\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff08\u30bf\u30b0\u30ea\u30c3\u30bd\uff09\u51e6\u65b9\u60c5\u5831\u3002<br data-start=\"200\" data-end=\"203\" data-is-only-node=\"\" \/> <a class=\"decorated-link\" href=\"https:\/\/www.fda.gov\" target=\"_new\" rel=\"noopener nofollow\" data-start=\"206\" data-end=\"225\">https:\/\/www.fda.gov<\/a> <\/p>\n<\/li>\n<li data-section-id=\"pqxfas\" data-start=\"227\" data-end=\"359\">\n<p data-start=\"230\" data-end=\"359\"><strong data-start=\"230\" data-end=\"266\">\u7c73\u56fd\u56fd\u7acb\u304c\u3093\u7814\u7a76\u6240\uff08NCI\uff09\u3002<\/strong><br data-start=\"266\" data-end=\"269\" \/>\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u6cbb\u7642\u306b\u304a\u3051\u308b\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u3002<br data-start=\"331\" data-end=\"334\" data-is-only-node=\"\" \/> <a class=\"decorated-link\" href=\"https:\/\/www.cancer.gov\" target=\"_new\" rel=\"noopener nofollow\" data-start=\"337\" data-end=\"359\">https:\/\/www.cancer.gov<\/a> <\/p>\n<\/li>\n<li data-section-id=\"lb3swt\" data-start=\"361\" data-end=\"517\">\n<p data-start=\"364\" data-end=\"517\"><strong data-start=\"364\" data-end=\"421\">\u7c73\u56fd\u56fd\u7acb\u751f\u7269\u5de5\u5b66\u60c5\u5831\u30bb\u30f3\u30bf\u30fc\uff08NCBI\uff09\u3002<\/strong><br data-start=\"421\" data-end=\"424\" \/> EGFR\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u3002<br data-start=\"483\" data-end=\"486\" data-is-only-node=\"\" \/> <a class=\"decorated-link\" href=\"https:\/\/www.ncbi.nlm.nih.gov\" target=\"_new\" rel=\"noopener nofollow\" data-start=\"489\" data-end=\"517\">https:\/\/www.ncbi.nlm.nih.gov<\/a> <\/p>\n<\/li>\n<li data-section-id=\"19ppivz\" data-start=\"519\" data-end=\"637\">\n<p data-start=\"522\" data-end=\"637\"><strong data-start=\"522\" data-end=\"553\">\u30d3\u30fc\u30b3\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u682a\u5f0f\u4f1a\u793e<\/strong><br data-start=\"553\" data-end=\"556\" \/>\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\u88fd\u54c1\u60c5\u5831\u3002<br data-start=\"600\" data-end=\"603\" data-is-only-node=\"\" \/> <a class=\"decorated-link\" href=\"https:\/\/www.beaconpharma.com.bd\" target=\"_new\" rel=\"noopener nofollow\" data-start=\"606\" data-end=\"637\">https:\/\/www.beaconpharma.com.bd<\/a><\/p>\n<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\uff1a\u7528\u9014\u3001\u52b9\u679c\u3001\u7528\u91cf\u3001\u4fa1\u683c \u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306e\u3054\u7d39\u4ecb \u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306f\u3001\u7279\u5b9a\u306e\u4e0a\u76ae\u6210\u9577\u56e0\u5b50\u53d7\u5bb9\u4f53\uff08EGFR\uff09\u5909\u7570\u3092\u6709\u3059\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\uff08NSCLC\uff09\u60a3\u8005\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u308b\u6a19\u7684\u304c\u3093\u6cbb\u7642\u85ac\u3067\u3059\u3002\u30d3\u30fc\u30b3\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u793e\u304c\u88fd\u9020\u3057\u3001\u7b2c3\u4e16\u4ee3\u30c1\u30ed\u30b7\u30f3\u30ad\u30ca\u30fc\u30bc\u963b\u5bb3\u5264\uff08TKI\uff09\u3067\u3042\u308b\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u3092\u542b\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u30bf\u30b0\u30ea\u30c3\u30af\u30b9\u30fb\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306f\u3001\u80ba\u304c\u3093\u306b\u304a\u3051\u308b\u5236\u5fa1\u4e0d\u80fd\u306a\u7d30\u80de\u5897\u6b96\u3068\u816b\u760d\u5f62\u6210\u3092\u5f15\u304d\u8d77\u3053\u3059\u7570\u5e38\u306aEGFR\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u3067\u4f5c\u7528\u3057\u307e\u3059\u3002\u3053\u306e\u6a19\u7684\u6cbb\u7642\u306f\u3001\u304c\u3093\u7d30\u80de\u306e\u9032\u884c\u3092\u9045\u3089\u305b\u305f\u308a\u3001\u505c\u6b62\u3055\u305b\u305f\u308a\u3059\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306f\u3001\u5c40\u6240\u9032\u884c\u6027\u307e\u305f\u306f\u8ee2\u79fb\u6027NSCLC\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u3066\u304a\u308a\u3001\u816b\u760d\u306bT790M\u5909\u7570\u304c\u751f\u3058\u305f\u5834\u5408\u3082\u542b\u307e\u308c\u307e\u3059\u3002T790M\u5909\u7570\u306f\u3001\u304c\u3093\u3092\u5f93\u6765\u306eEGFR-TKI\u7642\u6cd5\u306b\u5bfe\u3057\u3066\u8010\u6027\u306b\u3059\u308b\u3053\u3068\u304c\u591a\u3044\u5909\u7570\u3067\u3059\u3002\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u306f\u3001\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3068\u3057\u3066\u4e16\u754c\u7684\u306b\u5e83\u304f\u8a8d\u77e5\u3055\u308c\u3066\u304a\u308a\u3001\u591a\u304f\u306e\u56fd\u3067EGFR\u5909\u7570\u80ba\u304c\u3093\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306e\u7528\u9014 \u533b\u5e2b\u306f\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u3044\u304f\u3064\u304b\u306e\u80ba\u304c\u3093\u6cbb\u7642\u76ee\u7684\u3067\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u3092\u51e6\u65b9\u3059\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002 EGFR\u907a\u4f1d\u5b50\u5909\u7570\u3092\u6709\u3059\u308b\u8ee2\u79fb\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u7b2c\u4e00\u9078\u629e\u6cbb\u7642 \u4ee5\u524d\u306eEGFR\u963b\u5bb3\u5264\u306b\u5bfe\u3059\u308b\u8010\u6027\u3092\u793a\u3059T790M\u5909\u7570\u3092\u6709\u3059\u308b\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u6cbb\u7642 \u816b\u760d\u5207\u9664\u624b\u8853\u5f8c\u306e\u88dc\u52a9\u7642\u6cd5\u306b\u3088\u308b\u764c\u518d\u767a\u30ea\u30b9\u30af\u306e\u4f4e\u6e1b \u4ed6\u306eEGFR\u6a19\u7684\u7642\u6cd5\u5f8c\u306b\u764c\u304c\u9032\u884c\u3057\u305f\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642 \u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306e\u4f5c\u7528\u6a5f\u5e8f \u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\uff08\u30aa\u30b7\u30e1\u30eb\u30c1\u30cb\u30d6\uff09\u306f\u3001\u304c\u3093\u7d30\u80de\u306b\u5b58\u5728\u3059\u308b\u5909\u7570\u578bEGFR\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u6a19\u7684\u3068\u3057\u3066\u963b\u5bb3\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u306e\u85ac\u5264\u306f\u4ee5\u4e0b\u306e\u52b9\u679c\u3092\u767a\u63ee\u3057\u307e\u3059\u3002 \u304c\u3093\u7d30\u80de\u306e\u7570\u5e38\u306a\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u3092\u963b\u6b62\u3059\u308b \u816b\u760d\u306e\u5897\u6b96\u3092\u9045\u3089\u305b\u308b \u80ba\u304c\u3093\u7d30\u80de\u306e\u5897\u6b96\u3092\u963b\u6b62\u3059\u308b \u3053\u306e\u6a19\u7684\u6307\u5411\u578b\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308a\u3001\u85ac\u5264\u306f\u5065\u5eb7\u306a\u7d30\u80de\u3078\u306e\u30c0\u30e1\u30fc\u30b8\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u3064\u3064\u3001\u304c\u3093\u7d30\u80de\u3060\u3051\u3092\u7279\u7570\u7684\u306b\u653b\u6483\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308b\u3002 \u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u306e\u670d\u7528\u65b9\u6cd5 \u60a3\u8005\u306f\u3001\u30bf\u30b0\u30ea\u30c3\u30af\u30b980mg\u9320\u3092\u533b\u5e2b\u306e\u6307\u793a\u3069\u304a\u308a\u306b\u670d\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u4f7f\u7528\u4e0a\u306e\u6ce8\u610f\uff1a \u9320\u5264\u3092\u6c34\u3067\u4e38\u3054\u3068\u98f2\u307f\u8fbc\u3093\u3067\u304f\u3060\u3055\u3044\u3002 \u9320\u5264\u3092\u7815\u3044\u305f\u308a\u3001\u565b\u3093\u3060\u308a\u3001\u5272\u3063\u305f\u308a\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 \u98df\u4e8b\u306e\u6709\u7121\u306b\u304b\u304b\u308f\u3089\u305a\u670d\u7528\u3067\u304d\u307e\u3059<\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[3121],"product_cat":[15822,15818,15903],"product_tag":[20752,15912,15911,23727],"class_list":["post-40736","product","type-product","status-publish","product_brand-beacon-pharmaceuticals","product_cat-lung-cancer","product_cat-oncology","product_cat-speciality-medicines","product_tag-osimertinib","product_tag-strip","product_tag-tablet","product_tag-tagrix","pa_brand-name-tagrix","pa_molecule-osimertinib-ja","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product\/40736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/comments?post=40736"}],"version-history":[{"count":0,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product\/40736\/revisions"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/media?parent=40736"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product_brand?post=40736"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product_cat?post=40736"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/ja\/wp-json\/wp\/v2\/product_tag?post=40736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}